Online inquiry

IVTScrip™ mRNA-Anti-TNF, ABP 501(Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) (CAT#: GTTS-WQ1184MR)

This product GTTS-WQ1184MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP. It ecodes the monoclonal antibody that targets TNF gene. The antibody can be applied in Rheumatoid arthritis (RA) research.

Specifications
Product type	mRNA
Modified bases	5-Methyl-CTP
5' Cap	Cap 1
Species	Homo sapiens
RefSeq	NM_000594.4
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	7124
UniProt ID	P01375

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-TNF, ABP 501(Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) (GTTS-WQ1184MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ13547MR	IVTScrip™ mRNA-Anti-GPI-APs, PRX-302(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	PRX-302
GTTS-WQ10120MR	IVTScrip™ mRNA-Anti-LAG3, LAG-525(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	LAG-525
GTTS-WQ4317MR	IVTScrip™ mRNA-Anti-C1S, BIVV009(Cap 0, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	BIVV009
GTTS-WQ3598MR	IVTScrip™ mRNA-Anti-LYPD3, BAY 1129980(Cap 1, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	BAY 1129980
GTTS-WQ10280MR	IVTScrip™ mRNA-Anti-C5, LFG 316(Cap 1, 5-Methyl-CTP, 120 nt-poly(A))	mRNA	LFG 316
GTTS-WQ3938MR	IVTScrip™ mRNA-Anti-CTLA4, BCD-145(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	BCD-145
GTTS-WQ9003MR	IVTScrip™ mRNA-Anti-IL13, IMA-638(Cap 0, 2-Thio-UTP, 120 nt-poly(A))	mRNA	IMA-638
GTTS-WQ10629MR	IVTScrip™ mRNA-Anti-MAPT, LY-3303560(Cap 0, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	LY-3303560

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST